Proteins inform survival-based differences in patients with glioblastoma.
L C StetsonQuinn T OstromDaniela SchlatzerPeter LiaoKaren DevineKristin WaiteMarta E CoucePeggy L R HarrisAmber Kerstetter-FogleMichael E BerensAndrew E SloanMohammad M IslamVilashini RajaratnamShama P MirzaMark R ChanceJill S Barnholtz-SloanPublished in: Neuro-oncology advances (2020)
These proteomic datasets and noted protein variations present a beneficial resource for better predicting patient outcome and investigating potential therapeutic targets.